I

Infinity Clinical Research | Sunrise, FL

Research site

(Unclaimed)

Location

3537 N. Pine Island Road, Sunrise, Florida, United States of America

Site insights

Top conditions

Top treatments

Pimavanserin

Ocrelizumab

Atogepant

Lasmiditan

IPX203

Gantenerumab

SAR442168

Ozanimod

LY3303560

Dihydroergotamine

Parent organization

This site is a part of Infinity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 29 total trials

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease (BeyoND)

This is a multi-center, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa (LD/CD) delivered via a pump system as a...

Active, not recruiting

Parkinson's Disease

Drug: ND0612

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clarity AD)

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting

Early Alzheimer's Disease

Drug: Placebo

Drug: Lecanemab

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)

Primary Objective:To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio) measured by annualized adjudicated...

Active, not recruiting

Relapsing Multiple Sclerosis

Drug: Placebo to match Teriflunomide

Drug: Tolebrutinib